SymBiosis
Catherine Shoults, PhD MPH, currently serves as the AI and Analytics Lead at SymBiosis. With experience at UAMS, Orbis Biosciences, Quintiles, and Kansas Health Institute, Catherine has a strong background in informatics, drug development, clinical project management, and public health analysis. Catherine specializes in using Natural Language Processing tools to mine dark data and has been recognized for their work in machine learning in healthcare. Catherine holds a Master of Public Health from Yale University and a BS in Biology and Chemistry from Missouri State University.
This person is not in any teams
SymBiosis
SymBiosis is an investment firm focused on advancing biotherapeutics innovations for serious and life-threatening diseases. The firm invests in groundbreaking medicines across disease area, financing stage, and geography, with a focus on programs in, or about to enter, human trials. SymBiosis currently manages a portfolio of more than 30 investments and has significant, long-term capital commitments to fund future investments.